var path='https://www.tickertech.net';
function heading(heading) {
document.write('<p><table border="0" cellspacing="0" cellpadding="0" width="100%">'+
'<tr><td><span class="heading">&#149; '+heading+'</span></td></tr>'+
'<tr height="1" bgcolor="#EFEFEF"><td height="1">'+
'<img src="'+path+'/pics/tpixel.gif" width="1" height="1">'+
'</td></tr></table><p>');
}
function hiLite(imgDocID,imgObjName) {
document.images[imgDocID].src = eval(imgObjName + ".src");	
}
function showStatus(toshow) {
window.status = toshow;
}
function checkChoose() {
if (document.choose.ticker.value == "") {
alert("Please enter symbols before clicking the go button");
return false;
}
else return true;
}
function popJT(url,name){
var xwid = screen.width;
xwid = xwid - 10;
javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no');
javaticker.opener.name="opener";
//javaticker.moveTo(0,30);
}



	var allow = 0;
	var ref = ""+location;
	if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; }
	
function ShowTTIPage() {
if (allow) { document.write('<STYLE TYPE="text/css">\n'); }
if (allow) { document.write('<!-- \n'); }
if (allow) { document.write('.TTIptext, .TTIptext SELECT, .TTIptext INPUT {\n'); }
if (allow) { document.write('font-family: Arial,Helvetica,Times\;\n'); }
if (allow) { document.write('font-size:9pt\;\n'); }
if (allow) { document.write('color: #000000 \n'); }
if (allow) { document.write('}\n'); }
if (allow) { document.write('.menu {\n'); }
if (allow) { document.write('font-family: Arial,Helvetica,Times\;\n'); }
if (allow) { document.write('font-size:10pt\;\n'); }
if (allow) { document.write('color: #000000 \n'); }
if (allow) { document.write('}\n'); }
if (allow) { document.write('.menubld {\n'); }
if (allow) { document.write('font-family: Arial,Helvetica,Times\;\n'); }
if (allow) { document.write('font-size:10pt\;\n'); }
if (allow) { document.write('font-weight: bold\;\n'); }
if (allow) { document.write('color: #000000 \n'); }
if (allow) { document.write('}\n'); }
if (allow) { document.write('.heading {\n'); }
if (allow) { document.write('font-family: Arial,Helvetica,Times\;\n'); }
if (allow) { document.write('font-size: 12pt\;\n'); }
if (allow) { document.write('font-weight: bold\;\n'); }
if (allow) { document.write('font-color: black\;\n'); }
if (allow) { document.write('}\n'); }
if (allow) { document.write('a{text-decoration: underline}\n'); }
if (allow) { document.write('a.TTIplink:link{color:#222222}\n'); }
if (allow) { document.write('a.TTIplink:visited{color:#222222}\n'); }
if (allow) { document.write('a.TTIplink:active, a.TTIplink:hover{color:#555555}\n'); }
if (allow) { document.write('a.white:link, a.white:visited{color:#ffffff}\n'); }
if (allow) { document.write('a.white:active, a.white:hover{color:#dddddd}\n'); }
if (allow) { document.write('a.red:link, a.red:visited{color:#a50000}\n'); }
if (allow) { document.write('a.red:active, a.red:hover{color:#ff0000}\n'); }
if (allow) { document.write('-->\n'); }
if (allow) { document.write('</STYLE>\n'); }
if (allow) { document.write('<div name="ptnews" id="ptnews" style="width: 320px"></div>\n'); }
if (allow) { document.write('<table border="0" cellspacing="0" cellpadding="2" width="320">\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">4/30 - 7:30 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="http://m.theonlineinvestor.com/quotes/?a=news&ticker=a&w=&story=202404PZONE09108172" class="TTIplink">Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">4/9 - 8:30 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="http://m.theonlineinvestor.com/quotes/?a=news&ticker=a&w=&story=202404PZONE99086507" class="TTIplink">Tenax Therapeutics to Host KOL Event: "LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study"</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">3/28 - 8:30 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="http://m.theonlineinvestor.com/quotes/?a=news&ticker=a&w=&story=202403PZONE89080579" class="TTIplink">Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">3/12 - 8:30 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="http://m.theonlineinvestor.com/quotes/?a=news&ticker=a&w=&story=202403PZONE29061957" class="TTIplink">Tenax Therapeutics to Present at the 36th Annual Roth Conference</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">2/29 - 9:00 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="http://m.theonlineinvestor.com/quotes/?a=news&ticker=a&w=&story=202402PZONE99055801" class="TTIplink">Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">2/20 - 8:30 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="http://m.theonlineinvestor.com/quotes/?a=news&ticker=a&w=&story=202402PZONE09039631" class="TTIplink">Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">2/8 - 8:17 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="http://m.theonlineinvestor.com/quotes/?a=news&ticker=a&w=&story=202402PZONE89034296" class="TTIplink">Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">2/7 - 8:01 PM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="http://m.theonlineinvestor.com/quotes/?a=news&ticker=a&w=&story=202402PZONE89034019" class="TTIplink">Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103 (Oral Levosimendan) for the Treatment of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (PH-HFpEF)</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td valign="top" style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" nowrap><span class="TTIptext"><font color="#666666">2/6 - 8:30 AM&nbsp\;&nbsp\;</font></span></td>\n'); }
if (allow) { document.write('<td style="padding-top:6px\; padding-bottom: 6px\; border-bottom: 1px solid #EEEEEE\;" width="90%"><span class="TTIptext"><a href="http://m.theonlineinvestor.com/quotes/?a=news&ticker=a&w=&story=202402PZONE69032503" class="TTIplink">Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly Broadening IP Protection for Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)</a></span></td>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('<tr height="3"><td height="3"><img src="https://www.tickertech.net/pics/tpixel.gif" width="1" height="3" alt=""></td></tr>\n'); }
if (allow) { document.write('<tr>\n'); }
if (allow) { document.write('<td colspan="2"></td></form>\n'); }
if (allow) { document.write('</tr>\n'); }
if (allow) { document.write('</table>\n'); }
if (!allow) { document.write(''+ ''+
'	<h1>Access Denied</h1>'+
'	<h2><font color=red>Please Read This Important Message</font></h2>'+
'	If you are a paying TickerTech.com client and your account was not set up to include the configuration'+
'	received, please email <a href="mailto:support@tickertech.com" class="meta">support@tickertech.com</a>,'+
'	or call us at 1-866-515-2082 to verify your account settings.'+
'	'+
'	<br><br>'+
'	'+
'	<img src="https://www.tickertech.net/pics/caution.gif" width=16 height=16 alt="Note!"> If you reached this page'+
'	after attempting to place a TickerTech.com product onto your web page, go no further;  you must sign up as a'+
'	paying client.  For pricing information please visit our <a href="http://www.tickertech.com/products/">products page</a>, email '+
' 	<a href="mailto:services@tickertech.com">services@tickertech.com</a>, or give us a call at 1-866-515-2082.'+
' 	'+
' 	<br><br>'+
' 	'+
' 	<a href="http://www.tickertech.com/" class="meta">TickerTech.com home</a><br>'+
' 	<a href="http://www.tickertech.com/products/" class="meta">TickerTech.com products</a>'+
' 	<BR>'+
' 	'+
''); }

}